Sutro Biopharma, Inc.

NasdaqGM:STRO Stock Report

Market Cap: US$127.4m

Sutro Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:STRO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Oct 25BuyUS$39,950Connie MatsuiIndividual5,000US$7.99
15 Oct 25BuyUS$10,011Jane ChungIndividual1,250US$8.01
15 Oct 25BuyUS$15,998Gregory ChowIndividual1,975US$8.10
15 Oct 25BuyUS$13,607Hans-Peter GerberIndividual1,700US$8.00
15 Oct 25BuyUS$9,993David PaulingIndividual1,250.4US$7.99

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of STRO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders144,1941.69%
Hedge Funds2,358,45827.7%
General Public2,641,85931%
Institutions3,374,88039.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 65.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.78%
Affinity Asset Advisors, LLC
748,382US$11.2m894%0.89%
7.62%
Suvretta Capital Management, LLC
648,832US$9.7m0%0.27%
5.97%
Kynam Capital Management, LP
508,809US$7.6m0%0.38%
5.31%
Millennium Management LLC
452,435US$6.8m-4.39%no data
4.41%
The Vanguard Group, Inc.
375,786US$5.6m2.03%no data
3.98%
Acadian Asset Management LLC
338,932US$5.1m11.4%0.01%
3.66%
Velan Capital Partners LP
312,000US$4.7m1.96%2.99%
3.32%
Tang Capital Management, LLC
282,871US$4.2m10.4%0.13%
3.2%
MRL Ventures Fund LLC
272,350US$4.1m0%2.07%
3.05%
Vestal Point Capital, LP
260,000US$3.9m0%0.15%
2.69%
Eversept Partners, L.P.
229,131US$3.4m-0.04%0.22%
2.58%
Samsara BioCapital LLC
219,681US$3.3m0%0.3%
2.35%
Adage Capital Management, L.P.
200,000US$3.0m0%no data
1.98%
BlackRock, Inc.
168,788US$2.5m-19.9%no data
1.67%
Renaissance Technologies LLC
142,479US$2.1m56%no data
0.96%
Geode Capital Management, LLC
82,094US$1.2m0.49%no data
0.52%
Jacobs Levy Equity Management Inc
44,575US$666.4k0%no data
0.51%
Dafna Capital Management, LLC
43,707US$653.4k0%0.14%
0.48%
William Newell
40,906US$611.5k0%no data
0.47%
Two Sigma Investments, LP
39,678US$593.2k245%no data
0.41%
Fisher Asset Management, LLC
35,294US$527.6k0%no data
0.41%
AQR Capital Management, LLC
34,767US$519.8k-65.1%no data
0.4%
State Street Global Advisors, Inc.
34,265US$512.3k0%no data
0.37%
Shay Capital LLC
31,205US$466.5k20.1%0.08%
0.3%
RBC Dominion Securities Inc.
25,790US$385.6k16.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/02 09:10
End of Day Share Price 2026/01/30 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sutro Biopharma, Inc. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhiqiang ShuBerenberg
Tazeen AhmadBofA Global Research
Thomas ShraderBTIG